These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1450226)

  • 21. The value of bone marrow scintigraphy using 99mTc monoclonal antigranulocyte antibodies in complement to bone scintigraphy in detecting bone metastases from primary breast cancer.
    Prior JO; Barghouth G; Delaloye JF; Leyvraz S; Bischof Delaloye A
    Nucl Med Commun; 2003 Jan; 24(1):29-36. PubMed ID: 12501017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A re-evaluation of isotope screening for skeletal metastases in node-negative breast cancer.
    Gudgeon CA; Werner ID; Dent DM
    S Afr Med J; 1996 Feb; 86(2):166-9. PubMed ID: 8619145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of bone and liver metastases in breast cancer comparing tumor markers and imaging techniques.
    Zanco P; Rota G; Sportiello V; Borsato N; Ferlin G
    Int J Biol Markers; 1989; 4(2):103-5. PubMed ID: 2768888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is preoperative bone scintigraphy in early stage of breast cancer T1N0 indicated and meaningful?].
    Žaloudík J; Skovajsová M; Česlarová K; Bieberová L; Hussarová L; Zimovjanová M; Petruželka L
    Klin Onkol; 2013; 26(6):443-7. PubMed ID: 24320594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone Scintigraphy in Breast Cancer Patients in Ibadan, Nigeria.
    Ogundiran TO; Ayandipo OO; Adedapo KS; Orunmuyi AT; Ademola AF; Onimode YA; Ayeni OA; Alonge TO
    West Afr J Med; 2014; 33(3):172-7. PubMed ID: 26070820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparison of planar scintigraphy and MRI in the screening of skeletal metastases].
    Silit E; Başekim CC; Mutlu H; Pekkafali Z; Kizilkaya E; Karsli AF
    Tani Girisim Radyol; 2003 Sep; 9(3):357-61. PubMed ID: 14661604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum ostase in the follow-up of breast cancer patients.
    Marchei P; Santini D; Bianco V; Chiodini S; Reale MG; Simeoni F; Marchei GG; Vecchione A
    Anticancer Res; 1995; 15(5B):2217-22. PubMed ID: 8572628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of skeletal scintigraphy for oncological practice].
    Kampmann H; Buchelt L
    Rontgenblatter; 1983 Oct; 36(10):342-51. PubMed ID: 6227979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The status of nuclear medicine techniques in the diagnosis of bone metastases in breast cancer.
    Makaiová I; Kausitz J; Hupka S; Michaliková B; Vivodová M; Bohunický L
    Czech Med; 1989; 12(1):34-9. PubMed ID: 2498049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Status of skeletal scintigraphy, lung roentgen image and liver sonography in the follow-up of breast cancer].
    Schünemann H
    Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):379-84. PubMed ID: 2661306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone metastases and bone pain in breast cancer. Are they closely associated?
    Front D; Schneck SO; Frankel A; Robinson E
    JAMA; 1979 Oct; 242(16):1747-8. PubMed ID: 480600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone metastases in carcinoid tumors: clinical features, imaging characteristics, and markers of bone metabolism.
    Meijer WG; van der Veer E; Jager PL; van der Jagt EJ; Piers BA; Kema IP; de Vries EG; Willemse PH
    J Nucl Med; 2003 Feb; 44(2):184-91. PubMed ID: 12571207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bone scintigraphy in the preoperative determination of the stage of breast cancer].
    Denisov LE; Iarygin LM; Ermolaeva EV; Zhuravleva LI
    Med Radiol (Mosk); 1984 Jul; 29(7):5-8. PubMed ID: 6087080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The value of skeletal scintigraphy in the aftercare of breast carcinoma. A prospective study of 750 cases].
    Schünemann H; Jourdain M
    Dtsch Med Wochenschr; 1989 Jan; 114(1):3-8. PubMed ID: 2535982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
    Diel IJ; Solomayer EF; Seibel MJ; Pfeilschifter J; Maisenbacher H; Gollan C; Pecherstorfer M; Conradi R; Kehr G; Boehm E; Armbruster FP; Bastert G
    Clin Cancer Res; 1999 Dec; 5(12):3914-9. PubMed ID: 10632320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study.
    Yilmaz MH; Ozguroglu M; Mert D; Turna H; Demir G; Adaletli I; Ulus S; Halac M; Kanberoğlu K
    Med Oncol; 2008; 25(3):257-63. PubMed ID: 18040900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone scintigraphy in breast cancer: a nine-year follow-up.
    Kunkler IH; Merrick MV; Rodger A
    Clin Radiol; 1985 May; 36(3):279-82. PubMed ID: 4064511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The problem of false positives in bone scintigraphy in patients with breast neoplasms. A follow-up at 10 years].
    Campostrini F; Di Marco A; Micciolo R; Grandinetti A; Griso C; Palazzi M; Zamboni M
    Radiol Med; 1990 May; 79(5):539-43. PubMed ID: 2113699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer.
    Altehoefer C; Ghanem N; Högerle S; Moser E; Langer M
    Eur J Radiol; 2001 Oct; 40(1):16-23. PubMed ID: 11673003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of computed tomography in the detection of bone metastases in breast cancer patients.
    Muindi J; Coombes RC; Golding S; Powles TJ; Khan O; Husband J
    Br J Radiol; 1983 Apr; 56(664):233-6. PubMed ID: 6831145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.